Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2011, MEDEVICE Capital is a French venture capital fund based in France. The firm focuses on early-stage investments in the healthcare sector, particularly Medtech and digital health. MEDEVICE Capital has a portfolio of 10 companies and provides financial, strategic, and operational support to its portfolio.
MEDEVICE Capital invests in innovative startups that address significant medical needs within the Medtech and digital health sectors. The fund targets early-stage companies in France, with investment sizes ranging from €1 million to €1.5 million, and up to €4 million during Series A funding. They emphasize a quick time to market, aiming for companies that can launch within three years.
Notable portfolio companies include Certis Therapeutics, Dyameo, Emagina, Pixyl, Abolis, Avalun, Imactis, Bepatient, Eveon, and Koelis. Imactis recently signed an acquisition agreement with GE HealthCare for interventional radiology solutions.
Submit your pitch through their form at www.medevice.eu.
Yes, MEDEVICE Capital often leads investment rounds, particularly in the early stages of funding.
MEDEVICE Capital is open to follow-on investments, especially for companies that demonstrate significant growth potential and meet their strategic criteria.
The specific size of MEDEVICE Capital's current fund is not publicly disclosed, but they typically invest between €1 million and €4 million per company.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.